CN207886348U - A kind of dentistry postoperation hemostatic dressing - Google Patents
A kind of dentistry postoperation hemostatic dressing Download PDFInfo
- Publication number
- CN207886348U CN207886348U CN201720035215.6U CN201720035215U CN207886348U CN 207886348 U CN207886348 U CN 207886348U CN 201720035215 U CN201720035215 U CN 201720035215U CN 207886348 U CN207886348 U CN 207886348U
- Authority
- CN
- China
- Prior art keywords
- layer
- dentistry
- core layer
- auxiliary layer
- dressing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000002439 hemostatic effect Effects 0.000 title claims abstract description 32
- 239000010410 layer Substances 0.000 claims abstract description 40
- 239000012792 core layer Substances 0.000 claims abstract description 30
- 238000000059 patterning Methods 0.000 claims abstract description 7
- 229920001661 Chitosan Polymers 0.000 claims description 14
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 14
- IPWKIXLWTCNBKN-UHFFFAOYSA-N Madelen Chemical compound CC1=NC=C([N+]([O-])=O)N1CC(O)CCl IPWKIXLWTCNBKN-UHFFFAOYSA-N 0.000 claims description 13
- 229960002313 ornidazole Drugs 0.000 claims description 13
- FPVRUILUEYSIMD-RPRRAYFGSA-N [(8s,9r,10s,11s,13s,14s,16r,17r)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] acetate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(OC(C)=O)[C@@]1(C)C[C@@H]2O FPVRUILUEYSIMD-RPRRAYFGSA-N 0.000 claims description 6
- 229960003657 dexamethasone acetate Drugs 0.000 claims description 6
- 208000027418 Wounds and injury Diseases 0.000 abstract description 12
- 206010052428 Wound Diseases 0.000 abstract description 11
- 230000029663 wound healing Effects 0.000 abstract description 8
- 230000000740 bleeding effect Effects 0.000 abstract description 7
- 230000036592 analgesia Effects 0.000 abstract description 5
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 5
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 5
- 210000000214 mouth Anatomy 0.000 abstract description 4
- 208000030194 mouth disease Diseases 0.000 abstract description 3
- 201000001245 periodontitis Diseases 0.000 abstract description 3
- 230000002980 postoperative effect Effects 0.000 abstract description 3
- 239000012567 medical material Substances 0.000 abstract description 2
- 230000001737 promoting effect Effects 0.000 abstract description 2
- 230000008961 swelling Effects 0.000 abstract 1
- 208000032843 Hemorrhage Diseases 0.000 description 10
- 229940079593 drug Drugs 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 238000000605 extraction Methods 0.000 description 5
- 230000023597 hemostasis Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- 239000011148 porous material Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 229920000742 Cotton Polymers 0.000 description 3
- 230000002421 anti-septic effect Effects 0.000 description 2
- 230000003385 bacteriostatic effect Effects 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 210000003781 tooth socket Anatomy 0.000 description 2
- 235000009161 Espostoa lanata Nutrition 0.000 description 1
- 240000001624 Espostoa lanata Species 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- 208000031220 Hemophilia Diseases 0.000 description 1
- 208000009292 Hemophilia A Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000034693 Laceration Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 206010051077 Post procedural haemorrhage Diseases 0.000 description 1
- 208000037486 Postoperative Hemorrhage Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010051373 Wound haemorrhage Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 150000003851 azoles Chemical class 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 208000020670 canker sore Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 210000004195 gingiva Anatomy 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- 230000000025 haemostatic effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000002445 nipple Anatomy 0.000 description 1
- -1 nitre imidazoles Class Chemical class 0.000 description 1
- 208000004480 periapical periodontitis Diseases 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 1
- 210000003456 pulmonary alveoli Anatomy 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000009306 yunnan baiyao Substances 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
Abstract
The utility model belongs to medical material technical field, more particularly to a kind of dentistry postoperation hemostatic dressing, the bleeding-stopping dressing is in teeth patterning, it is made of core layer and auxiliary layer, the auxiliary layer is wrapped in core layer, the core layer is loose porous sponge structure, and the auxiliary layer is equipped with uniform mesh, is in uniform meshes structure.The dentistry postoperation hemostatic dressing not only has the function of good hemostatic analgesia, anti-inflammatory antibacterial, it can stop blooding to the oral cavities position such as gum, gum dentistry is postoperative, the effectively mouth diseases such as treatment gum pyorrhea, swelling and aching of gum, and can wound healing and the adhesion surface of a wound, under any oral environment（Moist, bleeding）There is splendid adhesion strength, is worth clinically promoting and applying.
Description
Technical field
The utility model belongs to medical material technical field, and in particular to a kind of dentistry postoperation hemostatic dressing.
Background technology
Tooth pulling surgery is common one of the operation of the department of stomatology, and postoperative hemorrhage of having tooth pulled out is common complication after extraction.Extraction
Cause of bleeding has systemic factor or local factor, and the targeted bleeding of the utility model patent is caused by local factor, such as tooth
Gum mucous membrane is torn, granulation tissue residual in tooth socket, and the small tracheal rupture of alveolus and tooth extraction wound clot corruption fall off；Periodontitis, root
Inflammation caused by periapical periodontitis makes surface of a wound long-time haemophilia after extraction；Operation causes gingival laceration bleeding and a few patients roughly
Since postoperative horse back jolts by bus, gargles too early, blood clot is made to fall off and cause bleeding.Currently, compression method is clinically the most frequently used
Traditional Hemostasis.Such as：Using the cotton roll of antiseptic gauze containing Yunnan Baiyao and simple antiseptic gauze cotton roll local compression tooth extraction wound
To reach hemostasis purpose.But cotton balls or gauze ball hemostasis are only physics Hemostasis, and reparation can not be played to the surface of a wound
Healing, while ideal haemostatic effect cannot be reached to larger surface of a wound bleeding.
Absorabable hemostatic gauze is using medical absorbent cotton/gauze as main raw material(s), using the technology and technique of innovation, makes natural
Fiber is made by controlled micro crystallization processing and cross-linking reaction, and absorabable hemostatic gauze has good water-soluble and salt dissolubility, hemostasis
Rapidly, it is a kind of good hemostatic material；But hemostatic gauze is acted on without antiphlogistic antibacterial, cannot prevent infection in tooth socket, limit
Its application in dentistry is made.In this case, research and development with good hemostatic analgesia, antiinflammatory and bacteriostatic functions and use
Convenient dentistry hemostatic material is extremely urgent.
Utility model content
The purpose of the utility model is to overcome existing dental dressings to have a single function, not easy to operate, cannot be played to the surface of a wound
Healing acts on, and be easy to cause the defect of secondary insult；A kind of dentistry postoperation hemostatic dressing is provided, it is simple in structure, it uses
It is convenient, there is good hemostatic analgesia, antiinflammatory and bacteriostatic functions, wound healing and the adhesion surface of a wound, under any oral environment
（Moist, bleeding）There is splendid adhesion strength.
To solve above-mentioned technical barrier, technical solution provided by the utility model is：
A kind of dentistry postoperation hemostatic dressing, the bleeding-stopping dressing are in teeth patterning, are made of core layer and auxiliary layer, institute
The auxiliary layer stated is wrapped in core layer, and the core layer is loose porous sponge structure, and the auxiliary layer is equipped with uniform
Mesh, be in uniform meshes structure.
Further, the core layer is made of absorabable hemostatic gauze in homogeneous thickness, and the thickness of core layer is 1 ~
3mm。
Preferably, a diameter of 1 ~ 2mm of the mesh.
Preferably, the auxiliary layer is anti-adhesion medical film.
Preferably, the anti-adhesion medical film is made of carboxymethyl chitosan.
Preferably, the carboxymethyl chitosan surface is covered with Ornidazole layer, and the Ornidazole layer surface is coated with vinegar
Sour dexamethasone.
Anti-adhesion medical film is set to, using carboxymethyl chitosan as pharmaceutical carrier, to fill in rice with being loaded with Ornidazole and acetic acid
The effect of the composite medical film of pine is, makes anti-adhesion medical film while having anti-blocking properties, can also play nitre difficult to understand
The effect of drug ingedient effect of azoles and dexamethasone acetate, i.e. antibacterial anti-inflammatory, convergence analgesia, wound healing.
Absorabable hemostatic gauze is used in combination with carboxymethyl chitosan composite membrane, overcomes absorabable hemostatic gauze without disappearing
The defect of scorching antibacterial action.The utility model not only has good hemostatic analgesia, effects of antiinflammation and bacteriostasis, moreover it is possible to wound healing
And the adhesion surface of a wound, under any oral environment（Moist, bleeding）There is splendid adhesion strength.
The beneficial effects of the utility model：
（1）The shape of the utility model is set as teeth patterning, meets mouth area physiological structure feature, can be very good
It is fixed near dentistry postoperative wound, it is not easily to fall off.Bleeding-stopping dressing is urged to wound area, bleeding-stopping dressing shape after about 3 minutes
Gelled.Bleeding-stopping dressing has perfect elasticity, will not change its stability being applied on oral cavity tissue, so both
Mechanical injuries ulcer can be prevented, is also possible to prevent to cause the blood supply of marginal gingiva nipple insufficient because of mechanical pressure.
（2）Core layer is prepared by loose porous absorabable hemostatic gauze, have good adhesiveness, gas permeability,
Biocompatibility can stop blooding rapidly and accelerate wound healing.
（3）Since the outer layer of absorabable hemostatic gauze is the anti-adhesion medical film for having network pore structure, it can both make core
Central layer stops blooding rapidly and absorbs wound exudate, and can prevent wound adhesion and effectively avoid the risk of wound secondary damage.
（4）Carboxymethyl chitosan is combined as pharmaceutical carrier and Ornidazole, and bacteriostasis property connection is played to the important anaerobic bacteria in oral cavity
Booster action is closed, while drug absorption can be promoted, delay drug release, is conducive to the treatment of mouth disease.Because of carboxymethyl chitosan
The slow releasing function of sugar, local drug concentration are stablized relatively, and drug dose is small, safe to use.Ornidazole is as novel nitre imidazoles
Class drug, it is fairly obvious to the therapeutic effect of the mouth diseases such as canker sore, periodontitis, gingivitis, and dexamethasone acetate can
The exudation of inflammatory tissue liquid is reduced, so, auxiliary layer can give full play to antibacterial anti-inflammatory, convergence analgesic, the work for promoting wound healing
With.
Description of the drawings
Fig. 1 is a kind of structural schematic diagram of dentistry postoperation hemostatic dressing of the utility model；
Reference sign：1 is core layer；2 be auxiliary layer.
Specific embodiment
The utility model is further described below in conjunction with the accompanying drawings.Following embodiment is only used for clearly illustrating this
The technical solution of utility model, and the scope of protection of the utility model cannot be limited with this.
Embodiment 1：
A kind of dentistry postoperation hemostatic dressing as shown in Figure 1 is in teeth patterning, is made of core layer 1 and auxiliary layer 2, auxiliary
Layer 2 is helped to be wrapped in core layer 1, core layer 1 is loose porous sponge structure, and auxiliary layer 2 is equipped with uniform mesh, is in uniform net
Pore structure.The core layer 1 is made of absorabable hemostatic gauze in homogeneous thickness, and the thickness of core layer 1 is 1mm.Described
Auxiliary layer 2 is anti-adhesion medical film, and the anti-adhesion medical film is made of carboxymethyl chitosan, and carboxymethyl chitosan surface is covered
There are Ornidazole layer, Ornidazole layer surface to be coated with dexamethasone acetate.A diameter of 1mm of 2 mesh of auxiliary layer.
Embodiment 2：
A kind of dentistry postoperation hemostatic dressing as shown in Figure 1 is in teeth patterning, is made of core layer 1 and auxiliary layer 2, auxiliary
Layer 2 is helped to be wrapped in core layer 1, core layer 1 is loose porous sponge structure, and auxiliary layer 2 is equipped with uniform mesh, is in uniform net
Pore structure.The core layer 1 is made of absorabable hemostatic gauze in homogeneous thickness, and the thickness of core layer 1 is 2mm.Described
Auxiliary layer 2 is anti-adhesion medical film, and the anti-adhesion medical film is made of carboxymethyl chitosan, and carboxymethyl chitosan surface is covered
There are Ornidazole layer, Ornidazole layer surface to be coated with dexamethasone acetate.A diameter of 1.5mm of 2 mesh of auxiliary layer.
Embodiment 3：
A kind of dentistry postoperation hemostatic dressing as shown in Figure 1 is in teeth patterning, is made of core layer 1 and auxiliary layer 2, auxiliary
Layer 2 is helped to be wrapped in core layer 1, core layer 1 is loose porous sponge structure, and auxiliary layer 2 is equipped with uniform mesh, is in uniform net
Pore structure.The core layer 1 is made of absorabable hemostatic gauze in homogeneous thickness, and the thickness of core layer 1 is 3mm.Described
Auxiliary layer 2 is anti-adhesion medical film, and the anti-adhesion medical film is made of carboxymethyl chitosan, and carboxymethyl chitosan surface is covered
There are Ornidazole layer, Ornidazole layer surface to be coated with dexamethasone acetate.A diameter of 2mm of 2 mesh of auxiliary layer.
Finally it should be noted that：Obviously, above-described embodiment is only intended to clearly illustrate the utility model example,
And it does not limit the embodiments.For those of ordinary skill in the art, may be used also on the basis of the above description
To make other variations or changes in different ways.There is no necessity and possibility to exhaust all the enbodiments.And thus
Among changes and variations that derived from are still in the scope of protection of the utility model.
Claims (3)
1. a kind of dentistry postoperation hemostatic dressing, which is characterized in that the bleeding-stopping dressing is in teeth patterning, by core layer and auxiliary
Layer is constituted, and the auxiliary layer is wrapped in core layer, and the core layer is loose porous sponge structure, the auxiliary layer
It is in uniform meshes structure equipped with uniform mesh；The auxiliary layer is anti-adhesion medical film；The anti-adhesion medical film by
Carboxymethyl chitosan is made；The carboxymethyl chitosan surface is covered with Ornidazole layer, and the Ornidazole layer surface is coated with
Dexamethasone acetate.
2. a kind of dentistry postoperation hemostatic dressing according to claim 1, which is characterized in that the core layer is equal by thickness
Even absorabable hemostatic gauze is constituted, and the thickness of core layer is 1 ~ 3mm.
3. a kind of dentistry postoperation hemostatic dressing according to claim 1, which is characterized in that a diameter of the 1 of the mesh ~
2mm。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201720035215.6U CN207886348U (en) | 2017-01-12 | 2017-01-12 | A kind of dentistry postoperation hemostatic dressing |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201720035215.6U CN207886348U (en) | 2017-01-12 | 2017-01-12 | A kind of dentistry postoperation hemostatic dressing |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN207886348U true CN207886348U (en) | 2018-09-21 |
Family
ID=63546445
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201720035215.6U Expired - Fee Related CN207886348U (en) | 2017-01-12 | 2017-01-12 | A kind of dentistry postoperation hemostatic dressing |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN207886348U (en) |
-
2017
- 2017-01-12 CN CN201720035215.6U patent/CN207886348U/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6568519B2 (en) | Medical covering device | |
| CN103142562B (en) | Sustained-release sticking film for treating oral ulcer | |
| US20070190110A1 (en) | Agents and devices for providing blood clotting functions to wounds | |
| CN111068097B (en) | Sterilizing and anti-inflammatory wound repair dressing and preparation method thereof | |
| CN111228040A (en) | Absorbable anti-adhesion dressing and preparation method thereof | |
| CN102850598B (en) | Alginate-gelatin-carboxymethylcellulose sodium blend membrane, and preparation and application thereof | |
| JP2016511310A5 (en) | ||
| AU2016269394A1 (en) | Topical oral gel formulations for dental use | |
| CN105833331A (en) | Preparation method for degradable biological wound dressing and obtained product | |
| JP2022523780A (en) | Antibacterial dressings, dressing components, and methods | |
| EP2315606A2 (en) | Formulations for a two-phase management of wound healing and dressings incorporating such formulations | |
| AT15430U1 (en) | Dental agent based on hyaluronan and octenidine dihydrochloride | |
| CN202458927U (en) | Nano-silver antimicrobial self-adhesive tape capable of powerfully sucking pus | |
| CN207886348U (en) | A kind of dentistry postoperation hemostatic dressing | |
| CZ12015U1 (en) | Preparation for preventing adhesion of a bandage to a wound | |
| CN204446300U (en) | A kind of composite medical dressing | |
| CN108969200A (en) | A kind of hospital gauze preventing adherency wound | |
| CN202207239U (en) | Novel wound plaster | |
| CN204147173U (en) | The compound dressing of a kind of activated carbon fiber | |
| CN202136481U (en) | Propolis band-aid | |
| ES2602179T3 (en) | A wound care device | |
| CN104001220B (en) | A kind of skin regeneration material and preparation method thereof | |
| CN211433138U (en) | Emergency department hemostasis bandage care implement | |
| CN205964288U (en) | Chitosan dressing | |
| CN219184527U (en) | Wound surface application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180921 |